Patients with a severe progressive form of multiple sclerosis will get access to the first licensed treatment for the condition after NICE recommended regular NHS funding for Roche's Ocrevus, although there are still restrictions on who will receive ...
Original Article: NICE backs Ocrevus for PPMS in England - but with caveats